Results from a recent study suggest that people with HIV whose antiretroviral regimen is taken as a single pill per day have better treatment adherence and a lower risk of hospitalization compared with people whose regimens consist of three or more pills per day.
“This study found that patients who receive [antiretroviral therapy] as a single pill per day are significantly more likely to be highly adherent to therapy. Furthermore, receiving a single pill per day was associated with a lower risk of hospitalization when compared with receiving multiple pills per day,” wrote the study authors.
“Although this study could not assess causality, it did show that receiving [antiretroviral therapy] as a single pill per day was associated with potential clinical and economic benefits,” they added.
According to the study investigators, high, sustained treatment adherence is necessary throughout a patient’s lifetime for optimal treatment outcomes. Studies in patients …Read the full story »